tiprankstipranks
Trending News
More News >
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
US Market

Prime Medicine, Inc. (PRME) Similar Stocks

Compare
654 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Prime Medicine, Inc.
$1.62
$196.94M
-71.34%
4 Buy
4 Hold
0 Sell
Moderate Buy
Editas Medicine
$2.35
$180.82M
-53.37%
4 Buy
5 Hold
1 Sell
Moderate Buy
Annexon Biosciences
$2.34
$267.70M
-53.85%
7 Buy
0 Hold
0 Sell
Strong Buy
Foghorn Therapeutics
$4.79
$244.70M
-9.18%
3 Buy
1 Hold
0 Sell
Strong Buy
Inhibikase Therapeutics
$1.74
$144.22M
14.09%
1 Buy
1 Hold
0 Sell
Moderate Buy
4D Molecular Therapeutics
$4.15
$202.44M
-82.05%
5 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PRME
Prime Medicine, Inc.
1.80
-4.35
-70.73%
EDIT
Editas Medicine
2.35
-2.69
-53.37%
ANNX
Annexon Biosciences
2.34
-2.86
-55.00%
FHTX
Foghorn Therapeutics
4.75
-0.49
-9.35%
IKT
Inhibikase Therapeutics
1.70
0.27
18.88%
FDMT
4D Molecular Therapeutics
4.09
-18.52
-81.91%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis